Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Feb 26,2021
Changes of Toxicological Equivalence Criteria
Key points in the latest 2012 revision of EU Sanco 10597/2003 Technical Equivalence Tier II data requirement are as below: 1. For ≥0.1% – <1% new or increased impurities: Ames study; 2. For 2. ≥1% new or increased impurities, 3 in vitro genotoxicity studies, and consider: a) Acute oral; b) Sensitization; c) Developmental study; d)Read more
More
Feb 26,2021
New drug toxicity testing service (European GLP/GCP standard)
The well-known European Institute of Toxicology and Experimental Medicine (Institut Toxikologie und Experimentelle Medizin, ITEM) is one of the most famous toxicology research institutions in Europe, and enjoys a world reputation especially in the research of respiratory toxicology. ITEM looks forward to cooperating with Chinese drug research and development institutions (pharmaceutical companies) in the safetyRead more
More
New drug toxicity testing service (European GLP/GCP standard)
Feb 25,2021
The importance of toxicological data to clinical trial design
Toxicological research is an important part of the non-clinical safety evaluation process of drugs. The purpose is to clarify the toxic reaction, dose correlation, toxicity and drug exposure of target organs before developing new drugs for humans and during clinical research. The reversibility of toxic reactions. This information is helpful for estimating the safe startingRead more
More
The importance of toxicological data to clinical trial design
Feb 25,2021
Discussion: Contents and procedures of "development and evaluation” of innovative drugs
In recent years, under the guidance of national policies, the development of domestic innovative drugs has been extremely hot. Many pharmaceutical companies have opened their own innovation departments, and whether it is to engage in projects on their own, or to buy projects in the BD department, and to develop innovative drugs, it seems thatRead more
More
Discussion: Contents and procedures of "development and evaluation” of innovative drugs
Feb 24,2021
Differences in the requirements of Chinese pharmacology and toxicology data for registration application
CFDA basic requirements for non-clinical pharmacology/toxicology content Study on primary and secondary pharmacodynamics and mechanism of action ● First determine the registration classification. The newer the registration classification and the newer the target, the more research on drug efficacy is needed, and different animal models should be used to illustrate the clinical and mechanism feasibilityRead more
More
Differences in the requirements of Chinese pharmacology and toxicology data for registration application
Feb 23,2021
Meaning of Toxicology Standards
Medicines are the crystallization of important weapons for mankind to protect itself against the outside world; in its research process, many disciplines and systems engineering are refined. There are many pharmacological accidents caused by drug safety issues in history, and they also gave birth to many evaluation systems. Today we are going to talk aboutRead more
More
Meaning of Toxicology Standards
Feb 23,2021
Toxicology in new drug development
There have been surveys showing that in the preclinical stage of drug candidates, toxicity problems are the main reason for development failures, accounting for about 40% of all development failures. It can be seen that in the early stages of development, detecting potential toxicity problems as early as possible and determining their safety as muchRead more
More
Toxicology in new drug development
Feb 22,2021
what is the process of Immunofluorescence?
Immunofluorescence technique (Immunofluorescence technique, IF), also known as fluorescent antibody technique, is one of the earliest developed labeling immunological techniques. In 1941, Coons and others successfully used fluorescein to label antibodies for the first time and established immunofluorescence technology. After decades of development, the technology has become quite mature.
More
what is the process of Immunofluorescence?
Feb 22,2021
Misunderstanding of immunofluorescence analysis
Recently, many fans have successively asked questions about "immunofluorescence” in the background, basically asking questions about immunofluorescence analysis. Here comes the problem. "Should immunofluorescence be analyzed?” Regarding this topic, I would like to discuss it carefully in a question-and-answer manner. In this way, people who read this article will not feel confused. Question 1: WhatRead more
More
Misunderstanding of immunofluorescence analysis
Feb 22,2021
Direct Immunofluorescence or Indirect Immunofluorescence Detection
Direct and indirect methods are not limited to immunofluorescence, they are also related to other technologies that rely on fluorescent dyes, enzymes or colored particles coupled to antibodies, such as flow cytometry, ELISA, and immunohistochemistry. But these two methods are different. As shown in the table below, both methods have their pros and cons: directRead more
More
Direct Immunofluorescence or Indirect Immunofluorescence Detection
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->